CLX Clorox

Q4 2025 10-Q

Filed: Feb 3, 2026Period ending Dec 31, 2025

Health Care

Specialty Cleaning, Polishing and Sanitation PreparationsSEC EDGAR

Clorox (CLX) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 3, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Management Discussion & Analysis

• Revenue $1.673B, down 1% YoY Q2 FY2025; six-month revenue $3.102B, down 10% YoY due to ERP transition and business divestitures
• Gross margin 43.2% vs 43.8% YoY Q2; six-month margin 42.5% vs 44.8% YoY, driven by higher manufacturing and logistics costs

+3 more insights

Risk Factors

• Section 'risk_factors' was empty or not found.

Quarterly Financial Summary
XBRL

Revenue

$1.7B

▼ -0.8% YoY▲ +17.1% QoQ

Net Income

$157M

▼ -18.7% YoY▲ +96.3% QoQ

Gross Margin

43.2%

▼ -62bp YoY▲ +145bp QoQ

Net Margin

9.4%

▼ -206bp YoY▲ +379bp QoQ

ROE

-125.6%

▲ +34513bp YoY

Total Assets

$5.6B

▲ +0.6% YoY

EPS (Diluted)

$1.28

▼ -16.9% YoY▲ +96.9% QoQ

Operating Cash Flow

$311M

▲ +72.8% YoY▲ +234.4% QoQ

Source: XBRL data from Clorox Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Clorox

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.